Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novoteris LLC
Garden Grove, California, United Statesnovoteris.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Novoteris has conducted a pilot trial that demonstrated more than a 15% increase in lung function following two weeks of therapy for cystic fibrosis patients. Their Phase II trials for cystic fibrosis are ongoing. A Phase II trial for COVID-19 was terminated due to low numbers of patients and funding issues.
- Therapeutic areas
- PulmonologyInfectious Diseases
- Modalities
- Gaseous nitric oxide formulations
- Industry
- Biotech
02
Partnerships
Mallinckrodt Inc.University of British ColumbiaUniversity of TorontoNitric Solutions
Beyond the preview
Go deeper on Novoteris LLC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novoteris LLC.